Our in vitro data suggest that Prodh may be a drug target against metastasis formation, which is supported by the fact that PRODH is significantly higher expressed in metastases compared to primary breast cancers in patients (P≤0.01, two-tailed unpaired Student's T-test with Welchs correction; Fig. 6a). The gene discussed is PRODH; the disease is breast cancer.